Recent Updates
Recently added Catalysts
RGEN Positive Sentiment Score: 70/100

Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

Key Takeaway: Repligen Corporation, targeting bioprocessing technology, announced its presentation at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco. CEO Tony J. Hunt will present on January 9, 2024, sharing insights into the company. A live webcast will be available on Repligen's Investor Relations website, emphasizing accessibility. This event signifies the company's proactive engagement in the biopharma industry.

Market Sentiment Analysis

POSITIVE FACTORS

  • Repligen Corporation will showcase its bioprocessing technology leadership.
  • CEO Tony J. Hunt will provide an overview, demonstrating company transparency.
  • The presentation at a prestigious conference highlights the company's visibility in the market.

Full Press Release Details

WALTHAM, Mass., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 42nd Annual J.P. Morgan Healthcare conference being held January 8-11 in San Francisco. Tony J. Hunt, Chief Executive Officer, will present an overview of the company on Tuesday, January 9, 2024, at 2:15 p.m. PST.
A live webcast of the presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.
About Repligen Corporation
Global Head of Investor Relations

Frequently Asked Questions

When will Repligen present at the J.P. Morgan Healthcare conference?

Repligen will present on January 9, 2024, at 2:15 p.m. PST.

Who is presenting for Repligen Corporation?

Tony J. Hunt, the CEO, will give the presentation.

Where can I watch the Repligen presentation live?

The live webcast will be available on Repligen’s Investor Relations website.

Will the Repligen presentation be available for replay?

Yes, the presentation will be available for replay for a limited time.

How can I contact Repligen's Investor Relations?

You can email investors@repligen.com for inquiries.

Last updated: Dec 19, 2023